未登录

D

Dannel Yeo

the university of sydney

H指数:17

被引数:917

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating Tumor Cells Predict Relapse in Head and Neck Mucosal Squamous Cell Carcinoma

循环肿瘤细胞预测头颈部黏膜鳞状细胞癌的复发

European Journal of Surgical Oncology

IF2.9

2025-12-110

OAAI

High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer

高间皮素表达与胰腺癌中低细胞毒性T细胞浸润相关

Frontiers in Immunology

IF5.9

2025-10-080

OAAI

Portal venous circulating tumor cells as a biomarker for relapse prediction in resected pancreatic cancer

门静脉循环肿瘤细胞作为切除后胰腺癌复发预测的生物标志物

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2025-04-100

OA

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

MOLECULAR ONCOLOGY

IF4.5

2024-07-020

OA

Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity

间皮素抗原密度对抗间皮素嵌合抗原受体T细胞细胞毒性的影响

IF3.2

2024-04-011

PRE

Detection of circulating tumor cells for the early detection of pancreatic cancer

CANCER RESEARCH

IF16.6

2024-01-160

PRE

High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma

IF4.1

2023-04-115

OAAI

Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging

FRONTIERS IN ONCOLOGY

IF3.3

2023-03-2711

OAAI

Locoregional delivery of CAR-T cells in the clinic

PHARMACOLOGICAL RESEARCH

IF10.5

2022-08-0114

OAAI

The next wave of cellular immunotherapies in pancreatic cancer

MOLECULAR THERAPY ONCOLYTICS

IF5.3

2022-03-0153

OAAI

Mapping oncogenic protein interactions for precision medicine

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2022-02-1412

OA

Anti-Mesothelin CAR T cell therapy for malignant mesothelioma

抗间皮素CAR T细胞治疗恶性间皮瘤

BIOMARKER RESEARCH

IF11.5

2021-02-1562

OAAI

Inhibition of Group 1 p21-Activated Kinases Suppresses Pancreatic Stellate Cell Activation and Increases Survival of Mice with Pancreatic Cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-02-0734

OAAI

FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine

IF3.4

2016-01-1646

OAAI

FRAX597, a PAK1 inhibitor, synergises with gemcitabine in the reduction of pancreatic cancer growth

ANNALS OF ONCOLOGY

IF65.4

2015-06-011

OAAI

Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease

轻度认知障碍和阿尔茨海默氏病的临床关联

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

IF2.8

2015-03-0943

PREAI

Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases

Glaucarubinone和吉西他滨通过下调P21-activated激酶协同降低胰腺癌的生长

IF10.1

2014-05-0155

OAAI

Diagnostic Performance of the Chinese Frontal Assessment Battery in Early Cognitive Impairment in an Asian Population

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

IF1.9

2011-01-2032

PREAI

Cognitive Screening in Asia: Recognizing the Role of the Patient-Family Unit

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

IF1.9

2010-04-242

PREAI